Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of the study was to compare 5 methods of delivering a weight loss lifestyle modification program to obese patients on a background of sibutramine. The methods differed in the type and frequency of counseling utilized to deliver dietary, physical activity and behavioral recommendations for weight loss.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Face-to-face counseling by a dietitian (months 1-3: weekly, months 4-6: every other week) | Behavioral | |||
| Face-to-face counseling by a dietitian (monthly) | Behavioral | |||
| Counseling by a dietitian via telephone (months 1-3: weekly, months 4-6: every other week) | Behavioral | |||
| Counseling by a dietitian via e-mail (months 1-3: weekly, months 4-6: every other week) | Behavioral | |||
| Self help | Behavioral |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage change in body weight at 6 months. |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in waist circumference, lipids, glucose, insulin, blood pressure, quality of life and weight-related symptoms at 6 months. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pfizer CT.gov Call Center | Pfizer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pfizer Investigational Site | Los Angeles | California | United States | |||
| Pfizer Investigational Site |
Not provided
| Label | URL |
|---|---|
| To obtain contact information for a study center near you, click here. | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Clearwater |
| Florida |
| United States |
| Pfizer Investigational Site | Kissimmee | Florida | United States |
| Pfizer Investigational Site | Pembroke Pines | Florida | United States |
| Pfizer Investigational Site | Lexington | Kentucky | United States |
| Pfizer Investigational Site | Louisville | Kentucky | United States |
| Pfizer Investigational Site | Milford | Massachusetts | United States |
| Pfizer Investigational Site | Charlotte | North Carolina | United States |
| Pfizer Investigational Site | Harleysville | Pennsylvania | United States |
| Pfizer Investigational Site | Warwick | Rhode Island | United States |
| Pfizer Investigational Site | Nashville | Tennessee | United States |
| Pfizer Investigational Site | Milwaukee | Wisconsin | United States |
| ID | Term |
|---|---|
| D009765 | Obesity |
| ID | Term |
|---|---|
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided